HOME > ARCHIVE

ARCHIVE

LDP Summarizes Its Proposals for Healthcare Reform

November 26, 2001
Post-marketing Safety Is Int'l Issue: Dr Doi

November 26, 2001
Marketing Approval Is Being Considered by Korosho : Seminar

November 26, 2001
REGULATORY NEWS IN BRIEF

November 26, 2001
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

November 26, 2001
DIAGNOSTIC NEWS IN BRIEF

November 26, 2001
CORPORATE ROUNDUP NEWS IN BRIEF -2-

November 26, 2001
WORLD NEWS IN BRIEF

November 26, 2001
BULLETIN

November 26, 2001
The 39th Annual Meeting of Japan Society of Clinical Oncology

November 26, 2001
CORPORATE ROUNDUP NEWS IN BRIEF -1-

November 26, 2001
RESEARCH AND DEVELOPMENT NEWS IN BRIEF

November 26, 2001
Precautions of 4 Drugs Including Carboplatin Revised Due to ADR

November 19, 2001
WORLD NEWS IN BRIEF

November 19, 2001
REGULATORY NEWS IN BRIEF

November 19, 2001
Sankyo Aims at US Sales of \360 Bil. in FY2010

November 19, 2001
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

November 19, 2001
Shionogi to Increase Overseas Sales to 10% of Total Sales in 2005

November 19, 2001
NEW PRODUCTS

November 19, 2001
Otsuka, BMS File NDA for New Antipsychotic Aripiprazole with FDA

November 19, 2001

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Beyond Elevidys: Next-Generation DMD Therapies Advance through Multiple Approaches

By Shinya Sato

The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…